(Q61453386)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Nitric oxide mediates the anticonvulsant effects of thalidomide on pentylenetetrazole-induced clonic seizures in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

main subject

behavioral neuroscience

0 references

author

Ahmad R. Dehpour

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Borna Payandemehr

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Reza Rahimian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Maziar Gooshe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Arash Bahremand

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ramtin Gholizadeh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Sina Berijani

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mohammad Ahmadi-Dastgerdi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Mehdi Aminizade

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Ali Sarreshte-Dari

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Vahid Dianati

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Massoud Amanlou

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

14 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

99-104

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

Thalidomide: A review of approved and investigational uses

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Effect of low-dose thalidomide on dopaminergic neuronal differentiation of human neural progenitor cells: a combined study of metabolomics and morphological analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide for treatment of refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Long-term treatment of thalidomide ameliorates amyloid-like pathology through inhibition of β-secretase in a mouse model of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Strong anticonvulsant effect of thalidomide on amygdaloid kindling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

PI3K/Akt signaling pathway is required for neuroprotection of thalidomide on hypoxic-ischemic cortical neurons in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide attenuates nitric oxide-driven angiogenesis by interacting with soluble guanylyl cyclase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Nitric oxide rescues thalidomide mediated teratogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide as a nitric oxide synthase inhibitor and its structural development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Phenylhomophthalimide-type NOS inhibitors derived from thalidomide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

5-HT(3) receptor mediates the dose-dependent effects of citalopram on pentylenetetrazole-induced clonic seizure in mice: involvement of nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

The proconvulsant effect of sildenafil in mice: role of nitric oxide-cGMP pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

The role of nitric oxide in the PKA inhibitor induced spatial memory deficits in rat: involvement of choline acetyltransferase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Involvement of nitric oxide-cGMP pathway in the anticonvulsant effects of lithium chloride on PTZ-induced seizure in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Agmatine enhances the anticonvulsant effect of lithium chloride on pentylenetetrazole-induced seizures in mice: Involvement of L-arginine/nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Role of nitric oxide in additive anticonvulsant effects of agmatine and morphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

The role of 5-HT(3) receptors in the additive anticonvulsant effects of citalopram and morphine on pentylenetetrazole-induced clonic seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Additive anticonvulsant effects of agmatine and lithium chloride on pentylenetetrazole-induced clonic seizure in mice: Involvement of α2-adrenoceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide inhibits pentylenetetrazole-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide: the tragedy of birth defects and the effective treatment of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Adverse effects of thalidomide administration in patients with neoplastic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of Inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

The role of nitric oxide in chemically- and electrically-induced seizures in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Role of nitric oxide in the genesis of excitatory amino acid-induced seizures from the deep prepiriform cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Nitric oxide and GABAA receptor function in the rat cerebral cortex and cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Thalidomide inhibits interferon-γ-mediated nitric oxide production in mouse vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

Impact of 5-HT₃ receptor antagonists on peripheral and central diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2014.03.020

10.1016/J.YEBEH.2014.03.020

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24735834%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference